| Amiloride | IC50 | 7000.0 [1], 11980.0 [2], 107000.0 [3] |
| Amiloride | Ki | 2433.0 [1], 2511.89 [2], 7000.0 [3] |
| 3-[(7R,10S,13S,19S,25S,28R,31S,34S,37S,40S,43S,46S,49R)-7-[(2-Amino-2-oxoethyl)carbamoyl]-49-[[(2S)-2-aminopropanoyl]amino]-19,25,43-tris(3-carbamimidamidopropyl)-31-(carboxymethyl)-13,46-bis(hydroxymethyl)-40-[(4-hydroxyphenyl)methyl]-10-methyl-9,12,15,18,21,24,27,30,33,36,39,42,45,48-tetradecaoxo-34-propan-2-yl-5,51,56-trithia-8,11,14,17,20,23,26,29,32,35,38,41,44,47-tetradecazatricyclo[26.26.3.13,53]octapentaconta-1(54),2,53(58)-trien-37-yl]propanoic acid | Ki | 53.0 [1] |
| 6-(N-Phenylcarbamyl)-2-naphthalenecarboxamidine | IC50 | 13000.0 [1] |
| 6-(N-Phenylcarbamyl)-2-naphthalenecarboxamidine | Ki | 630.0 [1], 630.96 [2], 631.0 [3], 1900.0 [4] |
| Benzo[b]thiophene-2-carboximidamide, 4-iodo- | IC50 | 210.0 [1] |
| Benzo[b]thiophene-2-carboximidamide, 4-iodo- | Ki | 79.43 [1], 210.0 [2], 320.0 [3] |
| Razaxaban | Ki | 2300.0 [1], 13000.0 [2] |
| Wx-uk1 free base | IC50 | 410.0 [1] |
| Wx-uk1 free base | Ki | 410.0 [1] |
| 1-Phenylguanidine | IC50 | 20000.0 [1] |
| 1-Phenylguanidine | Ki | 20600.0 [1], 20606.3 [2] |
| Naphthalene-2-carboximidamide | Ki | 5900.0 [1], 5910.0 [2], 6309.57 [3] |
| 1-(4-Chlorophenyl)guanidine | Ki | 6067.36 [1], 6070.0 [2], 6700.0 [3] |
| 2-{5-[Amino(iminio)methyl]-1H-benzimidazol-2-YL}benzenolate | Ki | 5500.0 [1] |
| 2-(2-Hydroxyphenyl)-1H-indole-5-carboxamidine | Ki | 2400.0 [1] |
| 3-[4-Chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]benzoic Acid | IC50 | 37.0 [1] |
| 3-[4-Chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]benzoic Acid | Ki | 37.0 [1] |
| 2-[[4-Chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-2-methylpropanoic acid | IC50 | 890.0 [1] |
| 2-[[4-Chloro-1-(diaminomethylideneamino)isoquinolin-7-yl]sulfonylamino]-2-methylpropanoic acid | Ki | 10.0 [1] |
| 6-[N-(4-(Aminomethyl)phenyl)carbamyl]-2-naphthalenecarboxamidine | IC50 | 1200.0 [1] |
| 6-[N-(4-(Aminomethyl)phenyl)carbamyl]-2-naphthalenecarboxamidine | Ki | 39.81 [1], 40.0 [2] |
| 6-[(Z)-Amino(imino)methyl]-N-[4-(aminomethyl)phenyl]-4-(pyrimidin-2-ylamino)-2-naphthamide | IC50 | 0.62 [1] |
| 6-[(Z)-Amino(imino)methyl]-N-[4-(aminomethyl)phenyl]-4-(pyrimidin-2-ylamino)-2-naphthamide | Ki | 0.62 [1], 0.63 [2] |
| 8-(Pyrimidin-2-ylamino)naphthalene-2-carboximidamide | Ki | 30.0 [1], 31.62 [2], 35.0 [3] |
| Amiloride hydrochloride dihydrate | IC50 | 11000.0 [1] |
| Amiloride hydrochloride dihydrate | Ki | 7000.0 [1] |
| (2R)-1-(2,6-Dimethylphenoxy)propan-2-amine | IC50 | 1000000.0 [1] |
| 5-(N,N-Hexamethylene)amiloride | IC50 | 2400.0 [1] |
| 5-(N,N-Hexamethylene)amiloride | Ki | 1356.0 [1] |
| 1-(3-Chlorophenyl)guanidine | Ki | 61659.5 [1], 61800.0 [2] |
| 4-Guanidinobenzoic acid | Ki | 744731.97 [1], 745000.0 [2] |
| 6-[2-(2-Methyl-1-propan-2-yl-3,4-dihydro-1H-isoquinolin-7-yl)cyclopropyl]naphthalene-2-carboximidamide | Ki | 47.0 [1], 50.12 [2] |
| 2-[3-(Aminomethyl)phenyl]-N-[2-fluoro-4-(2-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide;hydrochloride | Ki | 19000.0 [1] |
| Guanidine, N-2-pyridinyl- | Ki | 29000.0 [1], 29500.0 [2] |
| 3-{5-[Amino(iminio)methyl]-1H-indol-2-YL}-1,1'-biphenyl-2-olate | Ki | 8.0 [1] |
| 2-{5-[Amino(iminio)methyl]-1H-indol-2-YL}-6-bromo-4-methylbenzenolate | Ki | 55.0 [1], 110.0 [2] |
| N-(Benzylsulfonyl)seryl-N~1~-{4-[(Z)-amino(imino)methyl]benzyl}serinamide | IC50 | 20.0 [1] |
| N-(Benzylsulfonyl)seryl-N~1~-{4-[(Z)-amino(imino)methyl]benzyl}serinamide | Ki | 20.0 [1] |
| 1-(4-Methoxyphenyl)guanidine | Ki | 676000.0 [1], 676082.98 [2] |
| N-p-Tolyl-guanidine | Ki | 15595.53 [1], 15600.0 [2] |
| N-(2-Chloro-phenyl)-guanidine | Ki | 103000.0 [1], 103038.61 [2] |
| Benzenebutanamide, N-(4-(aminoiminomethyl)phenyl)-alpha-(((4-methylphenyl)sulfonyl)amino)- | IC50 | 10000.0 [1], 26000.0 [2] |
| 1-(4-Fluorophenyl)guanidine | Ki | 38904.51 [1], 72400.0 [2] |
| Ethyl N-[(2S)-6-amino-1-oxo-1-[5-[[4-(2-phenylethoxy)phenyl]methyl]-1,2,4-oxadiazol-3-yl]hexan-2-yl]carbamate | Ki | 150000.0 [1] |
| 4-[(E)-(5-Oxo-2-phenyl-1,3-oxazol-4-ylidene)methyl]benzenecarboximidamide | IC50 | 200.0 [1], 8670.0 [2] |
| 2-Amino-1H-benzo[d]imidazol-5-ol | IC50 | 10000.0 [1], 200000.0 [2] |
| 4-(4-Phenyl-2-thiazolyl)-5-(methylthio)thiophene-2-carboxamidine | Ki | 90.0 [1], 101.0 [2] |
| N-[4-(Trifluoromethyl)phenyl]guanidine | Ki | 6486.34 [1], 6490.0 [2] |
| 1-Piperazino-2-[(2-naphthyl)sulfonylamino]-3-(3-amidinophenyl)-1-propanone | Ki | 48000.0 [1] |
| 6-[(Z)-Amino(imino)methyl]-N-[3-(cyclopentyloxy)phenyl]-2-naphthamide | Ki | 25.12 [1], 28.0 [2] |
| 3-[2-(Naphthalene-2-sulfonylamino)-3-oxo-3-piperidin-1-yl-propyl]-benzamidine | Ki | 38000.0 [1] |
| N-[3-(Trifluoromethyl)phenyl]guanidine | Ki | 418793.57 [1], 419000.0 [2] |
| Diphenyl N-(benzyloxycarbonyl)amino(4-amidinophenyl)methanephosphonate | IC50 | 2500.0 [1], 60000.0 [2] |
| 4-[4-(4-Chlorophenyl)-2-thiazolyl]-5-(methylthio)thiophene-2-carboxamidine | Ki | 102.0 [1], 99000.0 [2] |
| 6-(2-(1-Isopropyl-3,4-dihydroisoquinolin-7-yl)cyclopropyl)-2-naphthimidamide | Ki | 125.89 [1], 139.0 [2] |
| 2-(3-Bromo-5-chloro-2-pyridinyl)guanidine | Ki | 4830.0 [1] |
| 6-Carbamimidoyl-4-(furan-3-yl)-N-phenylnaphthalene-2-carboxamide | Ki | 91.0 [1] |
| 6-Carbamimidoyl-N-phenyl-4-(pyrimidin-2-ylamino)naphthalene-2-carboxamide | Ki | 2.0 [1], 200.0 [2] |
| 6-Carbamimidoyl-4-(oxolan-3-yl)-N-phenylnaphthalene-2-carboxamide | Ki | 100.0 [1], 106.0 [2] |
| 5-Methylsulfanyl-thiophene-2-carboxamidine | Ki | 6000.0 [1] |
| 4-[(2R)-3-(3-Carbamimidoylphenyl)-2-(naphthalen-2-ylsulfonylamino)propanoyl]-N,N-dimethylpiperazine-1-carboxamide | IC50 | 10000.0 [1] |
| 4-[(2R)-3-(3-Carbamimidoylphenyl)-2-(naphthalen-2-ylsulfonylamino)propanoyl]-N,N-dimethylpiperazine-1-carboxamide | Ki | 28000.0 [1] |
| Benzyl N-[(2R)-1-[[(2S)-1-[[4-(diaminomethylideneamino)-1-diphenoxyphosphorylbutyl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamate | IC50 | 61.0 [1] |
| 6-Carbamimidoyl-N-(1-propan-2-yl-1,2,3,4-tetrahydroisoquinolin-7-yl)naphthalene-2-carboxamide | Ki | 23.5 [1], 25.12 [2] |
| 6-Carbamimidoyl-N-(3,5-dimethoxyphenyl)naphthalene-2-carboxamide | IC50 | 2600.0 [1] |
| 6-Carbamimidoyl-N-(3,5-dimethoxyphenyl)naphthalene-2-carboxamide | Ki | 139.0 [1] |
| 6-Carbamimidoyl-N-(3-propan-2-yloxyphenyl)naphthalene-2-carboxamide | Ki | 63.0 [1], 63.1 [2] |
| 3-Amino-N-[3-[[(2S)-3-(3-carbamimidoylphenyl)-1-[4-[2-(diaminomethylideneamino)ethyl]piperidin-1-yl]-1-oxopropan-2-yl]sulfamoyl]phenyl]propanamide | Ki | 1700.0 [1] |
| 3-Amino-N-[3-[[(2S)-1-[4-(2-aminoethyl)piperidin-1-yl]-3-(3-carbamimidoylphenyl)-1-oxopropan-2-yl]sulfamoyl]phenyl]propanamide | Ki | 3600.0 [1] |
| 6-Carbamimidoyl-N-(1,2,3,4-tetrahydroisoquinolin-6-yl)naphthalene-2-carboxamide | Ki | 15.85 [1], 16.5 [2] |
| N-[(1S)-5-Amino-1-cyanopentyl]-2-[[3-(4-fluorophenyl)-2,5-dioxoimidazolidin-1-yl]methyl]-3-methylbenzimidazole-5-carboxamide | IC50 | 200000.0 [1] |
| 1-(4-Bromophenyl)guanidine | Ki | 30690.22 [1], 30700.0 [2] |
| Methyl 4-[(diaminomethylidene)amino]benzoate | Ki | 1448771.85 [1], 1450000.0 [2] |
| (2R)-2-(Benzylsulfonylamino)-N-[(2S)-1-[[2-[4-(diaminomethylideneamino)phenyl]-1-diphenoxyphosphorylethyl]amino]-1-oxopropan-2-yl]-3-hydroxypropanamide | IC50 | 3.5 [1], 4.0 [2] |
| 8-[(2-Pyrimidinyl)amino]quinoline-2-amine | Ki | 370.0 [1], 2511.89 [2] |
| 6-Phenethyl-2-naphthimidamide | Ki | 3162.28 [1], 3183.0 [2] |
| 8-(Furan-2-yl)-7-methoxy-2-naphthimidamide | Ki | 1995.26 [1], 2100.0 [2] |
| 6-(2-Phenylcyclopropyl)-2-naphthimidamide | Ki | 1258.93 [1], 1310.0 [2] |
| 8-Aminonaphthalene-2-Carboximidamide | Ki | 450.0 [1], 501.19 [2] |
| 4-(2-Aminoethoxy)-N-(3-Chloro-2-Ethoxy-5-Piperidin-1-Ylphenyl)-3,5-Dimethylbenzamide | IC50 | 72.0 [1] |
| (2-Nitro-phenyl)-guanidine | Ki | 54300.0 [1], 54325.03 [2] |
| N-(4-Ethylphenyl)guanidine | Ki | 90700.0 [1], 90782.05 [2] |
| 6-(2-Phenylcyclopropyl)-8-(pyrimidin-2-ylamino)-2-naphthimidamide | Ki | 5.0 [1], 5.01 [2] |
| 8-Bromo-6-phenethyl-2-naphthimidamide | Ki | 1258.93 [1], 1370.0 [2] |
| 6-[N-(1-Isopropyl-3,4-dihydro-7-isoquinolinyl)carbamyl]-2-naphthalenecarboxamidine | Ki | 48.0 [1], 50.12 [2] |
| 3-[3-(4-Methylpiperidin-1-yl)-3-oxo-2-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]propyl]benzenecarboximidamide | Ki | 2000.0 [1] |
| 7-Methoxy-8-[1-(methylsulfonyl)-1H-pyrazol-4-YL]naphthalene-2-carboximidamide | Ki | 630.0 [1], 630.96 [2] |
| N-[(1S)-5-Amino-1-cyanopentyl]-6-[[2,5-dioxo-3-(4-phenoxyphenyl)imidazolidin-1-yl]methyl]-7-methylpyrrolo[2,3-d]pyrimidine-2-carboxamide | IC50 | 200000.0 [1], 400000.0 [2] |
| N-[(1S)-1-[4-(3-Amino-1H-indazol-6-yl)pyridin-2-yl]-2-phenylethyl]-4-(aminomethyl)cyclohexane-1-carboxamide | Ki | 14060.0 [1] |
| N-[(1S)-5-Amino-1-cyanopentyl]-6-[[3-(4-fluorophenyl)-2,5-dioxoimidazolidin-1-yl]methyl]-7-methylpyrrolo[2,3-d]pyrimidine-2-carboxamide | IC50 | 200000.0 [1], 1000000.0 [2] |
| CID 9799627 | Ki | 6.3 [1], 6.31 [2] |
| N-(Benzylsulfonyl)-D-Seryl-N-{4-[amino(Imino)methyl]benzyl}-L-Alaninamide | Ki | 7.7 [1] |
| 2-(2-Hydroxy-3-phenyl-5-methylphenyl)-1H-indole-5-carboxamidine | Ki | 38.0 [1], 110.0 [2] |
| Benzyl N-[(2R)-1-[[(2S)-1-[[2-[4-(diaminomethylideneamino)phenyl]-1-diphenoxyphosphorylethyl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamate | IC50 | 4.3 [1], 57.0 [2] |
| N-(2-Methoxy-phenyl)-guanidine | Ki | 136000.0 [1], 136144.47 [2] |
| 3-Amino-5-(azepan-1-yl)-6-(1-benzofuran-2-yl)-N-(diaminomethylidene)pyrazine-2-carboxamide | IC50 | 530.0 [1] |
| 3-Amino-5-(azepan-1-yl)-6-(1-benzofuran-2-yl)-N-(diaminomethylidene)pyrazine-2-carboxamide | Ki | 183.0 [1] |
| 3-Amino-5-(azepan-1-yl)-N-(diaminomethylidene)-6-(2-methoxypyrimidin-5-yl)pyrazine-2-carboxamide | IC50 | 39.0 [1] |
| 3-Amino-5-(azepan-1-yl)-N-(diaminomethylidene)-6-(2-methoxypyrimidin-5-yl)pyrazine-2-carboxamide | Ki | 53.0 [1] |